Columbus Regional Health has the ability to screen for lung cancer and identify it in early stages. Timely identification and ...
The treatment landscape for HER2-positive NSCLC is rapidly evolving as research continues to reveal the genetic drivers of these tumors. Emerging therapies like Pyrotinib (Jiangsu HengRui Medicine), ...